Positron emission tomography in the diagnosis of atherosclerotic plaques in cancer patients


如何引用文章

全文:

详细

Aim. To assess the capacities of radionuclide diagnosis of atherosclerotic changes in the great vessels in cancer patients.
Materials and methods. 18F-fluorodeoxyglucose positron emission tomography (PET) was used to image unstable atherosclerotic plaques in the aorta and great vessels. Whole-body radiodiagnostic studies were retrospectively analyzed in 500 cancer patients of different ages and with different forms of neoplasms.
Results. Tomographic images showed atherosclerotic plaques in 21% of the patients with the verified diagnosis of coronary heart disease (CHD) and in 17% without its clinical manifestations.
Conclusion. The study showed it possible to identify a cardiovascular risk in cancer patients

作者简介

Vladimir Sergienko

Ekaterina Panchkovskaya

Veronika Manukova

Marina Rudas

V Sergienko

Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies, Ministry of Health and Social Development of the Russian Federation

Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies, Ministry of Health and Social Development of the Russian Federation

E Panchkovsky

Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation

Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation

V Manukova

Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation

Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation

M Rudas

Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation

Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation

参考

  1. Чазов Е. И. Атеросклероз. М.: Медицина; 2000.
  2. Falk F., Shah P., Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671.
  3. Kohler T. Imaging of carotid artery lesions: a surgeon's view. In: Fuster V., ed. Syndromes of atherosclerosis: Correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Co., Inc.; 1996. 205-233.
  4. Davies J. R., Rudd J. H., Weissberg P. L. Molecular and metabolic imaging of atherosclerosis. J. Nucl. Med. 2004; 45 (11): 1898-1907.
  5. Беленков Ю. Н., Сергиенко В. Б. Роль неинвазивных методов исследования в диагностике атеросклероза. Кардиология 2007; 10: 2-6.
  6. Davies M. J. Acute coronary thrombosis: the role of plaque disruption and its initiation and prevention. Eur. Heart J. 1995; 16 (suppl. L): 3-7.
  7. Сергиенко В. Б. Радионуклидная диагностика в кардиологии. В кн.: Сторожаков Г. И. (ред.). Руководство по кардиологии. М.: Геотар Мед. 2008;т. 1: гл. 6, 169-187.
  8. Ambrose J. Angiographic correlations of advanced coronary lesions in acute coronary syndromes. In: Fuster V., ed. Syndromes of atherosclerosis: Correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Co., Inc.; 1996. 105-122.
  9. Taylor A. J., Baiery Merz C. N., Udelson J. E. 34-th Bethesda conference: Can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? J. Am. Coll. Cardiol. 2003; 41: 1855-1917.
  10. Bukrinsky M., Sviridov D. HIV and cardiovascular disease: Contribution of HIV-infected macrophages to development of atherosclerosis. Neurology 2007; 50 (9): 892-896.
  11. Mahmoudi M., Curzen N., Gallagher P. J. et al. Atherogenesis: the role of inflammation and infection. Rev. Esp. Cardiol. 2007; 60 (3): 268-275.
  12. Davies M. J. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley white lecture 1995. Circulation 1996; 94: 2013-2020.
  13. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850.
  14. Luscher T. F., Tanner F. C., Tschudi M. R., Noll G. Endothelial dysfunction in coronary artery disease. Annu. Rev. Med. 1993; 44: 395-418.
  15. Stefanadis C., Diamantopoulos L., Dernellis J. et al. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J. Mol. Cell. Cardiol. 2000; 32: 43-52.
  16. Dinsmore R. Imaging techniques in carotid and peripheral vascular disease. In: Fuster V., ed. Syndromes of atherosclerosis: Correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Co., Inc.; 1996. 277-289.
  17. Rudd J. H., Warburton E. A., Fryer T. D. et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105: 2708-2711.
  18. Yun M., Jang S., Cucciara A. et al. 18FDG uptake in the large arteries: a correlation study with the atherogenic risk factors Semin. Nucl. Med. 2002; 37: 70-76.
  19. Lederman R. J., Raylman R. R., Fisher S. J. et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl. Med. Commun. 2001; 22: 747-753.
  20. Vallabajosula S., Machac K., Knesaurek J. Imaging atherosclerotic macrophage density by positron emission tomography using F-18-flurodeoxyglucose (FDG) (abstract). J. Nucl. Med. 1996; 37 (suppl.): 38P.
  21. Strauss L. G., Conti P. S. The applications of PET in clinical oncology. J. Nucl. Med. 1991; 32: 623-648.
  22. Kubota R., Kubota K., Yamada S. et al. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J. Nucl. Med. 1994; 35: 104-112.
  23. Yun M., Yeh D., Araujo L. I. et al. F-18 FDG uptake in the large arteries: a new observation. Clin. Nucl. Med. 2001; 26: 314-319.
  24. Yun M., Jang S., Cucchiara A. et al. 18F-FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin. Nucl. Med. 2002; 32: 70-76.
  25. Ben-Haim S., Kupzov E., Tamir A., Israel O. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J. Nucl. Med. 2004; 45: 1816-1821.
  26. Bleeker-Rovers C., Bredie S., van der Meer J. et al. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth. J. Med. 2003; 61: 323-329.
  27. Rudd J. H., Warburton E. A., Fryer T. D. et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105: 2708-2711.
  28. Bjorkerud S., Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am. J. Pathol. 1996; 149: 367- 380.
  29. Davies J. R., Rudd J. H., Weissberg P. L. Molecular and metabolic imaging of atherosclerosis. J. Nucl. Med. 2004; 45 (11): 1898-1907.
  30. Lees R., Lees A. Radiopharmaceutical imaging of atherosclerosis. In: Fuster V., ed. Syndromes of atherosclerosis: Correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Co., Inc.; 1996. 385-401.
  31. Demacker P. N., Dormans T. P., Koenders E. B., Corstens F. H. Evaluation of indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol. J. Nucl. Med. 1993; 34: 1316- 1321.
  32. Chakrabarti M., Cheng K. T., Spicer K. M. et al. Biodistribution and radioimmunopharmacokinetics of 131J-AMA monoclonal antibody in atherosclerotic rabbits. Nucl. Med. Biol. 1995; 22: 693-695.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2010

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


##common.cookie##